WeChat Mini Program
Old Version Features

Measurable Residual Disease Testing Following Non-Intensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study

Julie E. Chang,Danielle McQuinn,Meredith Hyun,KyungMann Kim,Vaishalee P. Kenkre,Saurabh A. Rajguru,Priyanka A. Pophali, Mariah Endres,Mitch Howard,Tim Wassenaar, Ruth Callaway Warren,Ryan J. Mattison,Kari B. Wisinski,Christopher D. Fletcher

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited 0|Views3
Key words
Bendamustine,Mantle cell lymphoma,Measurable residual disease,Minimal residual disease,Next-generation sequencing,Obinutuzumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined